CLINICAL_TRIALS
trial_result
· 2015-07-08
Clinical Trial Update: Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast [NA]
Summary
The clinical trial evaluating lapatinib for ductal carcinoma in situ (DCIS) of the breast has been terminated, with results posted on 2015-07-08.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Ductal Carcinoma in Situ | NA | Status: TERMINATED | Results posted: 2015-07-08